SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Organogenesis Holdings Q1 EPS $0.07 Beats $(0.02) Estimate, Sales $102.60M Beat $87.57M Estimate

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.02) by 450 percent. This is a 143.75 percent increase over losses of $(0.16) per share

05/10/2021 16:24
Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.02) by 450 percent. This is a 143.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $102.60 million which beat the analyst consensus estimate of $87.57 million by 17.16 percent. This is a 66.20 percent increase over sales of $61.73 million the same period last year.